Invalid Symbol

Stock Research for PTX

Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

PTX Stock Chart & Research Data

The PTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PTX Due diligence Resources & Stock Charts

The PTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PTX Detailed Price Forecast - CNN Money CNN View PTX Detailed Summary - Google Finance
Yahoo View PTX Detailed Summary - Yahoo! Finance Zacks View PTX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View PTX Trends & Analysis - Trade-Ideas Barrons View PTX Major Holders - Barrons
NASDAQ View PTX Call Transcripts - NASDAQ Seeking View PTX Breaking News & Analysis - Seeking Alpha
Spotlight View PTX Annual Report - CompanySpotlight.com OTC Report View PTX OTC Short Report - OTCShortReport.com
TradeKing View PTX Fundamentals - TradeKing Charts View PTX SEC Filings - Bar Chart
WSJ View Historical Prices for PTX - The WSJ Morningstar View Performance/Total Return for PTX - Morningstar
MarketWatch View the Analyst Estimates for PTX - MarketWatch CNBC View the Earnings History for PTX - CNBC
StockMarketWatch View the PTX Earnings - StockMarketWatch MacroAxis View PTX Buy or Sell Recommendations - MacroAxis
Bullish View the PTX Bullish Patterns - American Bulls Short Pains View PTX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View PTX Stock Mentions - StockTwits PennyStocks View PTX Stock Mentions - PennyStockTweets
Twitter View PTX Stock Mentions - Twitter Invest Hub View PTX Investment Forum News - Investor Hub
Yahoo View PTX Stock Mentions - Yahoo! Message Board Seeking Alpha View PTX Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for PTX - SECform4.com Insider Cow View Insider Transactions for PTX - Insider Cow
CNBC View PTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PTX - OTC Markets
Yahoo View Insider Transactions for PTX - Yahoo! Finance NASDAQ View Institutional Holdings for PTX - NASDAQ


Stock Charts

FinViz View PTX Stock Insight & Charts - FinViz.com StockCharts View PTX Investment Charts - StockCharts.com
BarChart View PTX Stock Overview & Charts - BarChart Trading View View PTX User Generated Charts - Trading View


Latest Financial News for PTX

Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet® by Company’s Subsidiary, Macoven Pharmaceuticals
Posted on Friday February 16, 2018

MORRISTOWN, N.J., Feb. 16, 2018-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced the launch of an authorized generic version of Treximet ® in the U.S. by the Company’ ...


Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion
Posted on Tuesday February 06, 2018

Director John R. Leone Named as the Company’ s Lead Independent Director Angus Smith Promoted to Senior Vice President, Chief Business Officer and Principal Financial Officer. MORRISTOWN, N.J., Feb. 06, ...


Pernix Announces Patent Litigation Settlement Agreement with Actavis Concerning Zohydro® ER
Posted on Monday January 29, 2018

MORRISTOWN, N.J., Jan. 29, 2018-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced that it has entered into a settlement agreement with Actavis Laboratories FL resolving ...


Pernix Announces Reorganization of Sales Force to Focus on Zohydro® ER with BeadTek™ and Silenor®
Posted on Friday January 05, 2018

Anticipated Cost Savings of $7-$8 Million. MORRISTOWN, N.J., Jan. 05, 2018-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced that, due to the impending loss of exclusivity ...


Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet ...
Nasdaq - Feb 16, 2018
MORRISTOWN, N.J., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced the launch of an authorized generic version of Treximet® (sumatriptan/naproxen sodium) in the U.S ...
Pernix Therapeutics (PTX) Launches Generic Version of Treximet - StreetInsider.com

An Investor's Rationale To Staying Long Pernix Therapeutics
Seeking Alpha - Mar 24, 2017
Despite the pps, PTX has a intrinsic value beyond what is currently reflected in price. With9.5 million shares at last filing, plenty of options available to mgmt, especially options to not 'sell-out' to creditors.

Pernix Therapeutics Provides Update on Availability of Zohydro® ER with ...
GlobeNewswire (press release) - May 1, 2017
MORRISTOWN, N.J., May 01, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced that, due to a manufacturing issue with its supplier, the Company ...
Pernix Therapeutics Holdings (PTX) Stock: Gains On Sale Speculation Following ... - CNA Finance (press release)

Hold Consensus rating on stock: Pernix Therapeutics Holdings, Inc. (PTX)
Street Observer (press release) - 6 hours ago
Pernix Therapeutics Holdings, Inc. (PTX) stock price moved with surging change along with the volume 0.25 million shares in Friday trading session.

Enter a stock symbol to view the stock details.